• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTERSECT ENT PROPEL (MOMETASONE FUROATE IMPLANT 370 UG); DRUG ELUTING SINUS STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTERSECT ENT PROPEL (MOMETASONE FUROATE IMPLANT 370 UG); DRUG ELUTING SINUS STENT Back to Search Results
Model Number 70011
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Headache (1880); Inflammation (1932); Blurred Vision (2137)
Event Date 08/21/2014
Event Type  Injury  
Event Description
On (b)(6) 2014, a (b)(6) year old male with a history of chronic sinus disease and asthma underwent endoscopic sinus surgery and two propel sinus implants were placed bilaterally in the ethmoid sinuses.The pt was placed on antibiotics for 10 days post operatively.On day one, post-op packing was removed and daily saline sinus irrigations were started.On (b)(6) 2014 (2 weeks post-op) the pt complained of significant headache, decrease in visual acuity, and ocular pain.During the 2 week post-operative visit, the physician observed both peri-orbital and lamina papyracea inflammation; he opted to remove the implants and placed the pt on oral steroids.The pt was referred to an ophthalmologist, who did not observed any ocular pathology or prescribed any additional medications.A ct scan was performed and it was reported on (b)(6) 2014, that the sinuses were clear of any subsequent issues.The pt's eye symptoms had lessened, however he continued to experience headaches.This report is based on info available to the company at the time the report was due for submission and may not reflect all info that may ultimately become available through requests or analysis.
 
Manufacturer Narrative
Based on a review of internal records, the company was not able to establish a failure to meet specification.However, out of an abundance of caution, the company is submitting the report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROPEL (MOMETASONE FUROATE IMPLANT 370 UG)
Type of Device
DRUG ELUTING SINUS STENT
Manufacturer (Section D)
INTERSECT ENT
menlo park CA
Manufacturer Contact
amy wolbeck
1555 adams dr
menlo park, CA 94025
6506412115
MDR Report Key4117509
MDR Text Key19402369
Report Number3010101669-2014-00005
Device Sequence Number1
Product Code OWO
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P100044
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/22/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Expiration Date11/20/2015
Device Model Number70011
Device Catalogue Number70011
Device Lot Number40520001
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/22/2014
Initial Date FDA Received09/19/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age51 YR
-
-